University of Michigan's Rogel Cancer Center: Researchers At Rogel Cancer Center Circumvent Radiation Resistance In Subtype Of Brain Tumors
February 02, 2023
February 02, 2023
ANN ARBOR, Michigan, Feb. 2 (TNSjou) -- The University of Michigan's Rogel Cancer Center issued the following news release:
It's a good news, bad news story. Patients whose brain tumors have a mutated enzyme called IDH1 typically live longer than those without the mutation. But even as these tumors are initially less aggressive, they always come back. A key reason: The tumors are resistant to radiation treatment and are invasive.
In a study, researchers at the . . .
It's a good news, bad news story. Patients whose brain tumors have a mutated enzyme called IDH1 typically live longer than those without the mutation. But even as these tumors are initially less aggressive, they always come back. A key reason: The tumors are resistant to radiation treatment and are invasive.
In a study, researchers at the . . .